// App-Quantinova.ai

TCT-480 : The Predictive Value of Routine Biomarkers for Adverse Clinical Outcomes After Transcatheter Aortic Valve Replacement (TAVR)

Researchers

Presenter

  • Kris Atema

Principal Investigators

  • Kees van Bergeijk

  • Hindrik van der Werf

  • A. Van den Heuvel

  • Yvonne Douglas

  • Adriaan Voors

  • Joanna Wykrzykowska

Medical Centers

  • University Medical Center Groningen, Groningen, Netherland

  • UMCG, Groningen, the Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Stroke

Biomarkers

  • B-type natriuretic peptide

  • Creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved